Akèy › Abnormalite limfatik
Etid klinik pou Abnormalite limfatik ap rekrite nan Etazini
7 etid pou Abnormalite limfatik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Prospective Natural History Study of Lymphatic Anomalies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 100 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT05731141A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07285005Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Ap rekriteFaz 2/3
Laj 0 a 100 · Tout sèks · Mizajou Sep 18, 2026 · NCT05948943Lymphatic Anomalies Registry for the Assessment of Outcome Data
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 10, 2026 · NCT02399527A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06789913Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Ap rekriteFaz 2
6 Months – 18 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT05871970Weekly Sirolimus Therapy
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT04861064Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.